AI-generated summary
The authors retrospectively reviewed 100 patients with melasma treated with a 1927 nm fractional Thulium fiber laser, two sessions one month apart, scored with the MASI. They report that the mean MASI fell from 11.8 at baseline to 3.4 after the second session, with no major side effects, and describe the laser as safe and effective. Because the study is retrospective, these findings cannot establish causation.
- Participants
- 100
- Who or what was studied
- Patients with melasma seen at a dermatology outpatient clinic between September 2015 and March 2018 who received 1927 nm fractional Thulium fiber laser treatment
- Wavelengths
- 1927 nm
- Limits stated in the abstract
- The study is retrospective, and the abstract does not describe a control group or comparison treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1927 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.